A Psychedelic Trip from Forensics to the Clinical Lab
What do MDMA, Ketamine, Psilocybin, and DMT have in common? All four previously considered as "drugs of abuse" are now moving into the therapeutic space for life affirming treatments. In this episode, host Galina Dronova and Dr. Frederick Strathmann discuss the current limitations of laboratory testing and what the future holds. References Contact Dr. Frederick Strathmann: frederick.strathmann@mobilionsystems.com Psychedelic Movement Sees 2023 Catalysts in State Laws, Drug Trials Legal Use of Hallucinogenic Mushrooms Begins in Oregon Special thanks go out to our episode sponsor, the University of Cincinnati Online.